ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,884Medicare Part D Prescriptions Filled, Including Refills

Rank: 222 out of 676

$818K Total Retail Price of All Prescriptions

Rank: 97 out of 676

192 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 192 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 3,222 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
DIVALPROEX SODIUM ER 396 81 1 168
LEVOTHYROXINE SODIUM 370 118 2 7
SIMVASTATIN 346 213 3 6
CITALOPRAM HBR 328 98 4 17
RISPERIDONE 325 78 5 69
OMEPRAZOLE 253 92 6 2
RANITIDINE HCL 219 20 7 27
QUETIAPINE FUMARATE 211 66 8 72
AMLODIPINE BESYLATE 204 147 9 3
BENZTROPINE MESYLATE 191 36 R 10 129
DIOVAN 177 72 11 37
LISINOPRIL 174 52 12 5
ALENDRONATE SODIUM 165 110 13 61
LEVETIRACETAM 154 0 14 138
ABILIFY 123 0 15 133
PHENYTOIN SODIUM EXTENDED 119 12 16 88
FUROSEMIDE 113 55 17 4
CLONIDINE HCL 113 44 17 32
DIOVAN HCT 109 69 19 41
AMLODIPINE BESYLATE-BENAZEPRIL 103 22 20 44
HALOPERIDOL 99 26 21 158
METFORMIN HCL ER 98 63 22 63
CHLORPROMAZINE HCL 98 0 22 274
DIVALPROEX SODIUM 95 0 24 99
METOPROLOL SUCCINATE 95 41 24 14
METFORMIN HCL 95 0 24 8
MIRTAZAPINE 92 23 27 59
ATORVASTATIN CALCIUM 88 50 28 20
POTASSIUM CHLORIDE 87 34 29 9
OLANZAPINE 83 15 30 125
POLYETHYLENE GLYCOL 3350 82 0 31 56
CARBAMAZEPINE 81 0 32 217
SEROQUEL 80 21 33 135
ZIPRASIDONE HCL 80 0 33 294
NEXIUM 78 44 35 23
MELOXICAM 78 42 35 13
TRAZODONE HCL 76 14 37 36
RAMIPRIL 75 42 38 86
ATENOLOL 74 50 39 25
AMITIZA 73 0 40 264
LITHIUM CARBONATE 73 11 40 238
FLUOXETINE HCL 71 0 42 70
FLUTICASONE PROPIONATE 69 17 43 49
TRICOR 69 24 43 126
GABAPENTIN 66 12 45 10
FLUVOXAMINE MALEATE 64 0 46 341
ALLOPURINOL 63 12 47 31
LOVASTATIN 62 0 48 33
ZETIA 62 51 48 89
SERTRALINE HCL 60 13 50 26
TRIAMTERENE-HCTZ 58 0 51 43
PRAVASTATIN SODIUM 56 0 52 11
BENICAR HCT 53 53 53 180
HYDROCHLOROTHIAZIDE 51 22 54 12
EVISTA 51 39 54 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.